跳至主要内容
临床试验/NCT01939860
NCT01939860已完成不适用

A Feasibility Study of the Impact on Blood Pressure Control of Supplementing Community Pharmacist Services With Structured Information on Blood Pressure and Its Treatment

University of Warwick1 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2014年1月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
56
试验地点
1
主要终点
Changes in systolic or diastolic blood pressure

研究概览

简要总结

Hypertension is a major health problem, however its control is unsatisfactory. One of the reasons for such a high prevalence of this disease includes poor patient compliance to treatment. Approximately 30 % of newly diagnosed hypertensive patients stop taking their blood pressure medication by six months and 50% by 12 months.

The UK government is keen to encourage community pharmacists to play an active role in participation of services that can improve patient adherence to their medications. The New Medicines Service (NMS) and targeted Medicines Use Reviews (MUR) are established services which fund community pharmacists to review and explain medicine use to patients, with hypertension a common condition for which advice is given within these schemes. Within these schemes, advice is verbal and unstructured, with no specific written information provided on drugs or the disease being treated.

This study aims to determine whether structured information provided to participants verbally and in writing by community pharmacists about blood pressure and current medicine(s) within NMS and targeted MURs will be retained and will be associated with improved hypertension control. Participants will be recruited from people eligible for NMS and MURs and attending community pharmacies.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 or over 2) male or female 3) Have been started on any blood pressure medication

排除标准

  • Patients with English language problems

研究组 & 干预措施

Usual pharmacy care

No Intervention

Participants will not receive any structured written education on hypertension and its treatment

usual pharmacy care plus structured information

Experimental

Participants will be provided with validated verbal and written information on hypertension and its treatment, including information about class (es) of anti-hypertensive medication(s) used by each patient, and their common side-effects. The written material will be based on validated patient information leaflets from the British Heart Foundation and the Blood Pressure Association.

干预措施: Written and verbal patient education on hypertension and its treatment (Other)

结局指标

主要结局

Changes in systolic or diastolic blood pressure

时间窗: 1 year (trial would be stopped at 26 weeks if it is not possible to recruit any further participants

Systolic and diastolic blood pressure will be measured and recorded in mm Hg using OMRON blood pressure monitors

次要结局

  • change in the knowledge of hypertension(one year(trial would be stopped at 26 weeks if it is not possible to recruit any further participants))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ejaz Cheema

PhD student

University of Warwick

研究点 (1)

Loading locations...

相似试验